CPT code 0992T represents a specialized, noninvasive test that analyzes perivascular fat with dedicated software and integrates clinical data to assess a patient’s risk of heart problems. The analysis is interpreted by a qualified healthcare professional and results are delivered in a formal report. This novel imaging-derived risk assessment is distinct from, and not reported with, cardiac computed tomography services. Its adoption reflects growing interest in imaging biomarkers for cardiovascular risk stratification and has implications for diagnostic pathways and utilization of advanced post-processing tools.

Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national-level overview of the code’s clinical intent, expected sites of service, and how this service fits into cardiac imaging workflows. The publication also provides benchmarks and policy context where available, such as coding guidance, payer coverage tendencies, and clinical considerations for integrating perivascular fat analysis into practice. The content is designed to inform health system administrators, coding professionals, and clinical leaders about the purpose of CPT code 0992T, coverage landscape, and operational factors relevant to deploying this noninvasive cardiac risk assessment nationally.